Episode 41 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 3: Relevance and Impact of Novel Agents in Hemophilia Care Paradigms
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Episode 41 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 3: Relevance and Impact of Novel Agents in Hemophilia Care Paradigms
-
ナレーター：
-
著者：
このコンテンツについて
There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways.
Launch Date: February 4, 2025
Release Date: February 4, 2025
Expiration Date: January 31, 2026
FACULTY
Jonathan C. Roberts, MD
Associate Medical Director
Associate Research Director
Bleeding and Clotting Disorders Institute
Associate Professor of Pediatrics and Medicine
University of Illinois College of Medicine at Peoria
Mindy Simpson, MD
Medical Director
Rush Hemophilia and Thrombophilia Center
Assistant Professor of Pediatrics in Pediatric Hematology/Oncology
Rush University Medical Center
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.